Literature DB >> 31176097

Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.

Wen-Lin Tang1, Yu Zhang2, De-Xuan Hu2, Hui Yang2, Qian Yu2, Jian-Wen Chen2, Keli Agama3, Yves Pommier3, Lin-Kun An4.   

Abstract

DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI50 values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116 cell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antitumor; Benzophenanthridone; Cytotoxicity; DNA damage; Inhibitor; Topoisomerase

Mesh:

Substances:

Year:  2019        PMID: 31176097      PMCID: PMC8274952          DOI: 10.1016/j.ejmech.2019.05.074

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  36 in total

1.  Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282.

Authors:  Dhriti Sooryakumar; Thomas S Dexheimer; Beverly A Teicher; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2011-06-02       Impact factor: 6.261

Review 2.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

3.  DNA cleavage assay for the identification of topoisomerase I inhibitors.

Authors:  Thomas S Dexheimer; Yves Pommier
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 4.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

5.  A model for the mechanism of human topoisomerase I.

Authors:  L Stewart; M R Redinbo; X Qiu; W G Hol; J J Champoux
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

6.  NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma.

Authors:  Jenna H Burton; Christina Mazcko; Amy LeBlanc; Joseph M Covey; Jiuping Ji; Robert J Kinders; Ralph E Parchment; Chand Khanna; Melissa Paoloni; Sue Lana; Kristen Weishaar; Cheryl London; William Kisseberth; Erika Krick; David Vail; Michael Childress; Jeffrey N Bryan; Lisa Barber; E J Ehrhart; Michael Kent; Timothy Fan; Kelvin Kow; Nicole Northup; Heather Wilson-Robles; Joseph Tomaszewski; Julianne L Holleran; Miguel Muzzio; Julie Eiseman; Jan H Beumer; James H Doroshow; Yves Pommier
Journal:  Clin Cancer Res       Date:  2018-07-30       Impact factor: 12.531

7.  Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses.

Authors:  Ze-Hong Miao; Audrey Player; Uma Shankavaram; Yong-Hong Wang; Drazen B Zimonjic; Philip L Lorenzi; Zhi-Yong Liao; Hong Liu; Tsutomu Shimura; Hong-Liang Zhang; Ling-Hua Meng; Yong-Wei Zhang; Ernest S Kawasaki; Nicholas C Popescu; Mirit I Aladjem; David J Goldstein; John N Weinstein; Yves Pommier
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

8.  Protecting-group-free total synthesis of isoquinoline alkaloids by nickel-catalyzed annulation of o-halobenzaldimine with an alkyne as the key step.

Authors:  Rajendra Prasad Korivi; Chien-Hong Cheng
Journal:  Chemistry       Date:  2010-01-04       Impact factor: 5.236

Review 9.  DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition.

Authors:  Yves Pommier
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

10.  Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.

Authors:  Xiao-Ru Zhang; Hao-Wen Wang; Wen-Lin Tang; Yu Zhang; Hui Yang; De-Xuan Hu; Azhar Ravji; Christophe Marchand; Evgeny Kiselev; Kwabena Ofori-Atta; Keli Agama; Yves Pommier; Lin-Kun An
Journal:  J Med Chem       Date:  2018-10-31       Impact factor: 7.446

View more
  1 in total

1.  Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity.

Authors:  Mostafa M Elbadawi; Wagdy M Eldehna; Wenjie Wang; Keli K Agama; Yves Pommier; Manabu Abe
Journal:  Eur J Med Chem       Date:  2021-02-09       Impact factor: 7.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.